{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:52:21Z","timestamp":1781736741546,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04861-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:16:23Z","timestamp":1777504583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid abnormalities in chronic viral hepatitis: associations and machine learning\u2013enhanced prediction"],"prefix":"10.1186","volume":"26","author":[{"given":"Azra","family":"Bashir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshed Hussain","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Iqball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"4861_CR1","unstructured":"Swaroop S, Shalimar, Acharya SK. Hepatitis B virus prevalence in India: A wake-up call for action. Indian J Gastroenterol 2025 Jun 19:1\u20133."},{"key":"4861_CR2","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low-and middle-income countries. World Health Organization; 2024 Apr. p. 9."},{"issue":"4","key":"4861_CR3","first-page":"748","volume":"18","author":"N Shoaib","year":"2023","unstructured":"Shoaib N, Khan Z, Ibrahim M, Hafeez A, Fatima A, Imran H, Saleem F, Askari SM, Gull S. Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis. J Taibah Univ Med Sci. 2023;18(4):748\u201354.","journal-title":"J Taibah Univ Med Sci"},{"issue":"4","key":"4861_CR4","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4103\/aam.aam_35_21","volume":"21","author":"DS Meena","year":"2022","unstructured":"Meena DS, Kumar D, Garg MK, Meena M, Seju B, Bohra GK, Midha NK, Banerjee M. The Evaluation of Serum Lipid Profile in Chronic Hepatitis B Patients at a Tertiary Care Centre in Western India: A Cross-Sectional Study. Ann Afr Med. 2022;21(4):316\u201321.","journal-title":"Ann Afr Med"},{"issue":"6","key":"4861_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1872-034X.2011.00803.x","volume":"41","author":"T Miyazaki","year":"2011","unstructured":"Miyazaki T, Honda A, Ikegami T, Saitoh Y, Hirayama T, Hara T, Doy M, Matsuzaki Y. Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: An epidemiological survey of a large Japanese cohort. Hepatol Res. 2011;41(6):530\u201341.","journal-title":"Hepatol Res"},{"key":"4861_CR6","doi-asserted-by":"crossref","unstructured":"Farooque U, Lohano AK, Dahri Q, Arain N, Farukhuddin FN, Khadke C, Prince F, Farooque R, Shehata MA, Zafar MD. The pattern of dyslipidemia in chronic liver disease patients. Cureus. 2021;13(2).","DOI":"10.7759\/cureus.13259"},{"issue":"1","key":"4861_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5005\/jp-journals-10054-0202","volume":"26","author":"LW Jeris","year":"2023","unstructured":"Jeris LW, Thayub M, Bharati S, Cherian KM. Hypolipidemia: How Common Is It!! Indian J Med Biochem. 2023;26(1):34\u20136.","journal-title":"Indian J Med Biochem"},{"issue":"2","key":"4861_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.18203\/2349-3933.ijam20210083","volume":"8","author":"N Mathur","year":"2021","unstructured":"Mathur N, Mehta A, Mathur M, Hypolipidemia. A study evaluating magnitude and underlying etiologies of the entity. Int J Adv Med. 2021;8(2):183\u20135.","journal-title":"Int J Adv Med"},{"issue":"6","key":"4861_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","volume":"16","author":"C Bredefeld","year":"2022","unstructured":"Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charri\u00e8re S, Cuerq C, Davidson NO, Deckelbaum RJ, Goldberg IJ. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol. 2022;16(6):797\u2013812.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"4861_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0929-6646(11)60054-5","volume":"110","author":"YH Kuo","year":"2011","unstructured":"Kuo YH, Chuang TW, Hung CH, Chen CH, Wang JH, Hu TH, Lu SN, Lee CM. Reversal of hypolipidemia in chronic hepatitis C patients after successful antiviral therapy. J Formos Med Assoc. 2011;110(6):363\u201371.","journal-title":"J Formos Med Assoc"},{"issue":"36","key":"4861_CR11","doi-asserted-by":"publisher","first-page":"10299","DOI":"10.3748\/wjg.v21.i36.10299","volume":"21","author":"Y Aizawa","year":"2015","unstructured":"Aizawa Y, Seki N, Nagano T, Abe H. Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterology: WJG. 2015;21(36):10299.","journal-title":"World J Gastroenterology: WJG"},{"issue":"3","key":"4861_CR12","first-page":"201","volume":"10","author":"RA Iorga","year":"2020","unstructured":"Iorga RA, Bacalbasa N, Bratu OG, Radu FI, Diaconu CC. The impact of infection with hepatitis C virus on cardiovascular risk. Am J Cardiovasc Dis. 2020;10(3):201.","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"4861_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4103\/tcmj.tcmj_101_25","volume":"37","author":"CW Wang","year":"2025","unstructured":"Wang CW, Huang JF, Yu ML, Chuang WL. Hepatitis C virus and cardiovascular disease: Current knowledge and unmet needs. Tzu Chi Med J. 2025;37(4):371\u20137.","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"4861_CR14","doi-asserted-by":"publisher","first-page":"12081","DOI":"10.1038\/s41598-024-63095-8","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Shu Z, Chen S, Peng J, Zhao Y, Dai X, Li J, Zou X, Hu J, Huang H. A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients. Sci Rep. 2024;14(1):12081.","journal-title":"Sci Rep"},{"issue":"3","key":"4861_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4258\/hir.2019.25.3.173","volume":"25","author":"NH Barakat","year":"2019","unstructured":"Barakat NH, Barakat SH, Ahmed N. Prediction and staging of hepatic fibrosis in children with hepatitis C virus: A machine learning approach. Healthc Inf Res. 2019;25(3):173\u201381.","journal-title":"Healthc Inf Res"},{"key":"4861_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ebiom.2018.07.041","volume":"35","author":"R Wei","year":"2018","unstructured":"Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, Peng CY, Rajani C, Kwee S, Liu P, Jia W. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine. 2018;35:124\u201332.","journal-title":"EBioMedicine"},{"key":"4861_CR17","first-page":"3682","volume":"80","author":"K Arumugam","year":"2023","unstructured":"Arumugam K, Naved M, Shinde P, Leiva-Chauca O, Huaman-Osorio A, Gonzales-Yanac T. Multiple disease prediction using Machine learning algorithms. Mater today: Proc. 2023;80:3682\u20135.","journal-title":"Mater today: Proc"},{"issue":"2","key":"4861_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3402\/ljm.v3i2.4764","volume":"3","author":"RR Elmehdawi","year":"2008","unstructured":"Elmehdawi RR. Hypolipidemia: a word of caution. Libyan J Med. 2008;3(2):84\u201390.","journal-title":"Libyan J Med"},{"issue":"2","key":"4861_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/157016111794519354","volume":"9","author":"E Moutzouri","year":"2011","unstructured":"Moutzouri E, Elisaf M, Liberopoulos N. E Hypocholesterolemia Curr vascular Pharmacol. 2011;9(2):200\u201312.","journal-title":"E Hypocholesterolemia Curr vascular Pharmacol"},{"issue":"4","key":"4861_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjcard.2005.06.006","volume":"96","author":"NJ Stone","year":"2005","unstructured":"Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III update: adjustments and options. Am J Cardiol. 2005;96(4):53\u20139.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4861_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4103\/2230-8210.113753","volume":"17","author":"PG Talwalkar","year":"2013","unstructured":"Talwalkar PG, Sreenivas CG, Gulati A, Baxi H. Journey in guidelines for lipid management: From adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV. Indian J Endocrinol Metabol. 2013;17(4):628\u201335.","journal-title":"Indian J Endocrinol Metabol"},{"issue":"2","key":"4861_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0009-8981(97)06532-7","volume":"261","author":"C Fabris","year":"1997","unstructured":"Fabris C, Federico E, Soardo G, Falleti E, Pirisi M. Blood lipids of patients with chronic hepatitis: differences related to viral etiology. Clin Chim Acta. 1997;261(2):159\u201365.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"4861_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1665-2681(19)31484-X","volume":"11","author":"MA Khattab","year":"2012","unstructured":"Khattab MA, Eslam M, Aly MM, Shatat M, Mousa YI, Abd-Aalhalim H, Aly H, Shaker Y. Serum lipids and chronic hepatitis C genotype 4: interaction and significance. Ann Hepatol. 2012;11(1):37\u201346.","journal-title":"Ann Hepatol"},{"issue":"2","key":"4861_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biomedicines11020271","volume":"11","author":"W Elgretli","year":"2023","unstructured":"Elgretli W, Chen T, Kronfli N, Sebastiani G. Hepatitis C virus-lipid interplay: pathogenesis and clinical impact. Biomedicines. 2023;11(2):271.","journal-title":"Biomedicines"},{"issue":"6","key":"4861_CR25","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","volume":"4","author":"B Paul","year":"2022","unstructured":"Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Rep. 2022;4(6):100479.","journal-title":"JHEP Rep"},{"issue":"1","key":"4861_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12944-018-0683-y","volume":"17","author":"SQ Arain","year":"2018","unstructured":"Arain SQ, Talpur FN, Channa NA, Ali MS, Afridi HI. Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B. Lipids Health Dis. 2018;17(1):36.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"4861_CR27","doi-asserted-by":"publisher","first-page":"42710","DOI":"10.1038\/srep42710","volume":"7","author":"T Wu","year":"2017","unstructured":"Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, Panee J, Jia W, Ji G. Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients. Sci Rep. 2017;7(1):42710.","journal-title":"Sci Rep"},{"issue":"3","key":"4861_CR28","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejim.2014.01.006","volume":"25","author":"P Jar\u010du\u0161ka","year":"2014","unstructured":"Jar\u010du\u0161ka P, Jani\u010dko M, Kru\u017eliak P, Nov\u00e1k M, Vesel\u00edny E, Feda\u010dko J, Senajov\u00e1 G, Dra\u017eilov\u00e1 S, Madarasov\u00e1-Geckov\u00e1 A, Marekov\u00e1 M, Pella D. Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study. Eur J Intern Med. 2014;25(3):286\u201391.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"4861_CR29","first-page":"18","volume":"1","author":"N Rane","year":"2024","unstructured":"Rane N, Choudhary SP, Rane J. Ensemble deep learning and machine learning: applications, opportunities, challenges, and future directions. Stud Med Health Sci. 2024;1(2):18\u201341.","journal-title":"Stud Med Health Sci"},{"issue":"4","key":"4861_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jama.2015.37","volume":"313","author":"M Fitzgerald","year":"2015","unstructured":"Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. JAMA. 2015;313(4):409\u201310.","journal-title":"JAMA"},{"key":"4861_CR31","doi-asserted-by":"crossref","unstructured":"Sadatsafavi M, Adibi A, Puhan M, Gershon A, Aaron SD, Sin DD. Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models. Eur Respir J. 2021 Sep 9.","DOI":"10.1183\/13993003.01186-2021"},{"issue":"2","key":"4861_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/biomedicines11020581","volume":"11","author":"AQ Md","year":"2023","unstructured":"Md AQ, Kulkarni S, Joshua CJ, Vaichole T, Mohan S, Iwendi C. Enhanced preprocessing approach using ensemble machine learning algorithms for detecting liver disease. Biomedicines. 2023;11(2):581.","journal-title":"Biomedicines"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04861-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04861-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04861-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:27:27Z","timestamp":1781735247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04861-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4861"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04861-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was duly approved by the Institutional Review Board (IRB) under reference no. IRBGMC\/Radio\/1358. The informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}